The new vaccine, known as M72/AS01E, was tested at 11 sites in Kenya,
South Africa and Zambia in adults whose blood tests showed they had
latent TB. The study revealed that the vaccine could cut the number of
people developing TB by half.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/gsks-tuberculosis-vaccine-shows-promising-results/articleshow/71803087.cms
No comments:
Post a Comment